Incorporating Data From Text Messages and Email Into Psychotherapy: Randomized Controlled Trial
Background: As digital communication becomes central to daily life, psychotherapy increasingly has access to patients’ electronic media data. Although digital phenotyping has been widely studied, less is known about whether incorporating personal communication data, such as text messages, improves clinical outcomes in psychotherapy. Objective: This study aimed to determine whether integrating personalized text message data into psychotherapy improves depression, anxiety, health-related quality of life, and therapeutic alliance and to examine whether increased access to collateral information influences clinical decision-making. Methods: The Electronic Media and its Impact on Psychotherapy (EMAP) study was a randomized controlled trial conducted in adult and geriatric outpatient and partial hospitalization settings at an academic psychiatric hospital. Participants receiving psychotherapy for primary depression or anxiety (n=101) were randomized to electronic media–enhanced therapy (EME; n=52) or treatment as usual (TAU; n=49). In EME, research staff reviewed participants’ text messages prior to sessions using personalized mood-related key terms and presented aggregated findings on a Health Insurance Portability and Accountability Act (HIPAA)–compliant clinician dashboard. TAU participants received standard care without message review. Outcomes included change scores for the Patient Health Questionnaire-9 (PHQ-9), the Generalized Anxiety Disorder-7 (GAD-7), the 36-item Short Form Health Survey (SF-36), and the Working Alliance Inventory–Short Revised (WAI-SR). Linear regression and nonparametric tests compared groups. Moderation analyses assessed whether the frequency of information access influenced treatment changes. Results: No statistically significant between-group differences were observed in anxiety or working alliance. Among participants with SF-36 follow-up data (n=65), EME participants demonstrated greater improvement in the pain subscale. Greater frequency of information access was associated with increased treatment-related changes in the EME group. Access to additional collateral information was associated with more clinical actions but not with improved distal outcomes. Conclusions: Integrating personalized text message data into short-term psychotherapy did not significantly improve depression or anxiety, and it neither improved nor worsened therapeutic alliance. However, access to greater amounts of collateral information, including electronic media, influenced clinical decision-making, suggesting nuanced and context-dependent effects. Trial Registration: ClinicalTrials.gov NCT03712267; https://clinicaltrials.gov/study/NCT03712267
<img src="https://jmir-production.s3.us-east-2.amazonaws.com/thumbs/83d4b3baa71dab46e45ae5a24d70bd35" />
Symptom Trajectories and Attendance in Face-to-Face and Online Psychiatric Follow-Up for Major Depressive Disorder and Anxiety Symptoms: Prospective Observational Cohort Study
Bridgedd, a Health Care Staff–Facing Community Resource Navigation Tool for an Urban Safety-Net Hospital: Cross-Sectional Formative Pilot Study
Background: Health care professionals in safety-net settings often rely on lengthy and inconsistently maintained community health resource lists when connecting patients with services. Bridgedd is a health care staff–facing web application designed to generate geographically and categorically filtered community resources in a unique format that makes information about each resource more accessible. Objective: This formative pilot study aimed to characterize the perceptions of behavioral health professionals toward Bridgedd’s usability, comparative value relative to existing community resource filtering and communication tools, and their intent to use it with patients if made available. Methods: We conducted a single-site, cross-sectional formative pilot of the web-based tool we developed, Bridgedd, within Grady Health System’s Integrated Behavioral Health Program between April 23 and May 14, 2026. All 21 program team members attending an all-staff meeting received a presentation about Bridgedd and were given the opportunity to try the tool and ask questions. Then, they independently evaluated it using a self-generated hypothetical patient scenario. Eleven completed an investigator-developed anonymous feedback survey assessing perceived ease of use, comparative value relative to existing tools, intent to use the tool with patients, and open-ended feedback. Quantitative responses were summarized using raw counts, and open-ended responses were summarized as descriptive observations. A post hoc descriptive analysis excluded 2 potentially direction-confused response patterns. The post hoc descriptive analysis did not materially change the overall interpretation. Results: Eleven behavioral health professionals (therapists, n=4; licensed professional counselors, n=3; social workers, n=2; mental health counselor, n=1; certified peer specialist–mental health, n=1) completed the survey. Of the 11 respondents, 9 rated the tool as very easy to use, none reported technical problems, 8 agreed or strongly agreed that Bridgedd was better than the tools they currently use to help patients navigate community health resources, and 8 reported an intent to use the tool with patients if it were made available. In the open-ended responses, 7 of the 11 respondents suggested that nothing was missing or offered no additional suggestions for improvement, while the remaining 4 open-ended responses centered on expanding mental or behavioral health resources, providing additional county coverage, including more resources within each category, and building a mechanism for updating resource information. Conclusions: In this small, single-setting formative pilot study using hypothetical patient scenarios, participating behavioral health professionals generally reported favorable perceptions of Bridgedd’s usability and potential utility. Further evaluation during routine clinical care is needed to assess actual use, workflow effects, patient experience, referral completion, and patient-level outcomes.
<img src="https://jmir-production.s3.us-east-2.amazonaws.com/thumbs/a8c6492be29f23ca898f5ed912520f71" />
“There is a Place for it”—Practitioners’ Perspectives on Situated Ethical Acceptability of AI Technologies for Mental Health Practice: Qualitative Study
Background: Design research on AI technologies for mental health has expanded rapidly, yet existing work has largely focused on practitioners’ perspectives within isolated therapeutic stages or specific services. As a result, there is limited understanding of how practitioners view the role of AI across the full therapeutic journey, including assessment, diagnosis, and treatment, or how these perspectives can be translated into actionable and ethically grounded design guidance. This lack of stage-specific guidance introduces several risks: (1) the development of AI tools that practitioners may not trust or adopt, (2) heightened ethical concerns, particularly in diagnosis where bias and erosion of human judgment are most likely, and (3) missed opportunities to leverage AI to support ongoing assessment and treatment adaptation. Objective: This study aimed to explore mental health practitioners’ perspectives on how AI may support or hinder therapeutic practice across all 3 therapeutic stages, with particular attention to their ethical considerations. Methods: We conducted semistructured interviews with 18 mental health practitioners to explore how AI may support or hinder therapeutic practice across assessment, diagnosis, and treatment. Data were analyzed thematically, and ethical challenges were organized using 4 biomedical principles. This study received approval from the Lancaster University Institutional Ethics Committee (ID 3530). Results: Findings suggest a stage-specific pattern: practitioners identified valuable roles for AI in supporting clinical assessment and treatment, while expressing strong resistance to autonomous AI diagnosis, which was regarded as the most ethically sensitive stage. Across contexts, AI was seen as supporting and validating, rather than replacing, clinical judgment. Ethical concerns were organized using these principles, with key issues including data validity, inclusivity, privacy, transparency, and explainability. Grounded in these findings, four design directions are proposed: (1) AI-enabled clinical assessment hubs for analyzing multimodal patient data to support transparent decision-making; (2) natural language processing-based tools to enable richer understanding of patients’ lived experiences; (3) new models of trust to support ethically sensitive AI-assisted diagnostic decision-making; and (4) large language model–powered personalized and adaptive mental health support systems that maintain human-AI partnership and preserve practitioners’ central role in care. Conclusions: This study provides a stage-specific understanding of practitioners’ perspectives on AI use across assessment, diagnosis, and treatment and systematically frames ethical challenges using biomedical principles. The findings translate practitioner insights into actionable design guidance for ethically informed AI-supported mental health practice.
<img src="https://jmir-production.s3.us-east-2.amazonaws.com/thumbs/e0b7a00e31b823d08a966ec23073fab6" />

